Literature DB >> 25597004

Iminosugars as a new class of cholinesterase inhibitors.

Camille Decroocq1, Fabien Stauffert1, Olivier Pamlard2, Farah Oulaïdi3, Estelle Gallienne3, Olivier R Martin3, Catherine Guillou4, Philippe Compain5.   

Abstract

To further extend the scope of iminosugar biological activity, a systematic structure-activity relationship investigation has been performed by synthesizing and evaluating as cholinesterase inhibitors a library of twenty-three iminoalditols with different substitutions and stereochemistry patterns. These compounds have been evaluated in vitro for the inhibition of cholinesterases (different sources of acetylcholinesterase and butyrylcholinesterase). Some compounds have IC50 values in the micromolar range and display significant inhibition selectivity for butyrylcholinesterase over acetylcholinesterase. These are the first examples of iminosugar-based inhibitors of cholinesterases.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Cholinesterases; Iminosugars; Inhibitors

Mesh:

Substances:

Year:  2014        PMID: 25597004     DOI: 10.1016/j.bmcl.2014.12.071

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.

Authors:  João Paulo B Lopes; Luana Silva; Diogo S Lüdtke
Journal:  RSC Med Chem       Date:  2021-09-08

2.  Design, synthesis and photochemical properties of the first examples of iminosugar clusters based on fluorescent cores.

Authors:  Mathieu L Lepage; Antoine Mirloup; Manon Ripoll; Fabien Stauffert; Anne Bodlenner; Raymond Ziessel; Philippe Compain
Journal:  Beilstein J Org Chem       Date:  2015-05-06       Impact factor: 2.883

3.  Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist.

Authors:  Xiaocong Pang; Ying Zhao; Junke Song; Song Wu; Lin Wang; Ailin Liu; Guanhua Du
Journal:  Mol Med Rep       Date:  2019-05-28       Impact factor: 2.952

4.  Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors.

Authors:  Ana I Ahuja-Casarín; Penélope Merino-Montiel; José Luis Vega-Baez; Sara Montiel-Smith; Miguel X Fernandes; Irene Lagunes; Inés Maya; José M Padrón; Óscar López; José G Fernández-Bolaños
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE).

Authors:  Tereza Cristina Santos Evangelista; Óscar López; Adrián Puerta; Miguel X Fernandes; Sabrina Baptista Ferreira; José M Padrón; José G Fernández-Bolaños; Magne O Sydnes; Emil Lindbäck
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.